BLACKSBURG, Va.--(BUSINESS WIRE)--Intrexon, a developer of biotherapeutic control systems to enhance the safety and efficacy of existing and novel biological therapeutics, today announced the appointment of Sunil Chada, Ph.D as the Senior Vice President of Clinical Research and Development and an Officer of the Company. Dr. Chada will report directly to Intrexon’s Chief Executive Officer, Robert Beech and will be responsible for all aspects of the Company’s pre-clinical and clinical development programs.
